-
Enoximone
- indication:For the treatment of congestive heart failure.
- pharmacologypharmacology:
- mechanism: Further research is required to determine accurately the mechanism of action of drugs with phosphodiesterase inhibitory activity.
- toxicity:
- absorprion: Bioavailabvility is 50% following oral administration.
- halflife: 4-10 hours
- roouteelimination:
- volumedistribution:
- clearance: